GlassScriptPhysician profile
Melissa S Parrish
NPI 1285264879
$1,226.69
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $418 · 2022: $676 · 2023: $107 · 2024: $24.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $131.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $279.93 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $204.41 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $126.12 | 2022-2023 | Spravato |
| Novo Nordisk INC | $125.00 | 2021 | |
| Ironshore Pharmaceuticals INC. | $81.85 | 2021-2022 | |
| Tris Pharma INC | $74.65 | 2022-2023 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $57.45 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $51.29 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $39.40 | 2021-2023 | Rexulti |
| Alkermes, INC. | $29.81 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $27.42 | 2021 | |
| Lundbeck LLC | $24.91 | 2021 | |
| Corium, LLC | $21.55 | 2023-2024 | Azstarys |
| Indivior INC. | $21.53 | 2021 | |
| Idorsia Pharmaceuticals US INC | $17.99 | 2023 | Quviviq |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $16.91 | 2024 | Cobenfy |
| Astrazeneca Pharmaceuticals LP | $13.49 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Parrish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.